NVP-BEZ235 (Dactolisib) acted as a dual PI3K/mTOR inhibitor and was shown to inhibit cervical cancer cell proliferation while inducing apoptosis in cellular assays. The gene discussed is MTOR; the disease is cervical carcinoma.